Logo image of SEER

SEER INC (SEER) Stock Overview

USA - NASDAQ:SEER - US81578P1066 - Common Stock

2.31 USD
+0.14 (+6.45%)
Last: 10/24/2025, 8:00:02 PM

SEER Key Statistics, Chart & Performance

Key Statistics
Market Cap130.15M
Revenue(TTM)16.29M
Net Income(TTM)-82114000
Shares56.34M
Float50.52M
52 Week High2.63
52 Week Low1.62
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.39
PEN/A
Fwd PEN/A
Earnings (Next)11-06 2025-11-06/amc
IPO2020-12-04
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


SEER short term performance overview.The bars show the price performance of SEER in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15

SEER long term performance overview.The bars show the price performance of SEER in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 -40 -60

The current stock price of SEER is 2.31 USD. In the past month the price increased by 1.76%. In the past year, price increased by 23.53%.

SEER INC / SEER Daily stock chart

SEER Latest News, Press Relases and Analysis

SEER Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.56 216.18B
DHR DANAHER CORP 28.92 159.69B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 148.65 48.49B
A AGILENT TECHNOLOGIES INC 27.16 41.97B
IQV IQVIA HOLDINGS INC 19.23 37.49B
MTD METTLER-TOLEDO INTERNATIONAL 35.07 29.55B
WST WEST PHARMACEUTICAL SERVICES 42.07 21.39B
WAT WATERS CORP 29.39 21.40B
MEDP MEDPACE HOLDINGS INC 42.32 17.00B
ILMN ILLUMINA INC 24.06 15.39B
TEM TEMPUS AI INC N/A 15.50B
ICLR ICON PLC 13.5 13.85B

About SEER

Company Profile

SEER logo image Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. The company is headquartered in Redwood City, California and currently employs 134 full-time employees. The company went IPO on 2020-12-04. The company is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. The company has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.

Company Info

SEER INC

3800 Bridge Parkway, Suite 102

Redwood City CALIFORNIA US

Employees: 134

SEER Company Website

SEER Investor Relations

Phone: 16504530000

SEER INC / SEER FAQ

Can you describe the business of SEER INC?

Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. The company is headquartered in Redwood City, California and currently employs 134 full-time employees. The company went IPO on 2020-12-04. The company is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. The company has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.


What is the stock price of SEER INC today?

The current stock price of SEER is 2.31 USD. The price increased by 6.45% in the last trading session.


What is the dividend status of SEER INC?

SEER does not pay a dividend.


What is the ChartMill rating of SEER INC stock?

SEER has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Where is SEER INC (SEER) stock traded?

SEER stock is listed on the Nasdaq exchange.


What is the Price/Earnings (PE) ratio of SEER INC (SEER)?

SEER INC (SEER) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.39).


Should I buy SEER stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SEER.


SEER Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to SEER. When comparing the yearly performance of all stocks, SEER is one of the better performing stocks in the market, outperforming 74.48% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

SEER Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to SEER. While SEER has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SEER Financial Highlights

Over the last trailing twelve months SEER reported a non-GAAP Earnings per Share(EPS) of -1.39. The EPS decreased by -8.59% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -25.46%
ROE -28.48%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%5.71%
Sales Q2Q%31.87%
EPS 1Y (TTM)-8.59%
Revenue 1Y (TTM)10.53%

SEER Forecast & Estimates

7 analysts have analysed SEER and the average price target is 3.06 USD. This implies a price increase of 32.47% is expected in the next year compared to the current price of 2.31.

For the next year, analysts expect an EPS growth of 3.75% and a revenue growth 23.95% for SEER


Analysts
Analysts82.86
Price Target3.06 (32.47%)
EPS Next Y3.75%
Revenue Next Year23.95%

SEER Ownership

Ownership
Inst Owners62.64%
Ins Owners3.27%
Short Float %3.12%
Short Ratio12.49